PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein

Nature Structural and Molecular Biology

Volumn 11, Issue 11, 2004, Pages 1114-1121

  Daniels, Matthew J ^a   Marson, Alexander ^a   Venkitaraman, Ashok R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; DEPOLYMERIZATION; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MICROTUBULE; MITOSIS INHIBITION; MITOSIS SPINDLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN ISOLATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; CHROMOSOME ABERRATIONS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; INTRANUCLEAR INCLUSION BODIES; MICE; MICROSCOPY, FLUORESCENCE; MITOSIS; MODELS, GENETIC; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGENES; TUMOR SUPPRESSOR PROTEINS; XENOPUS; XENOPUS LAEVIS;

EID: 7544227866     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb837     Document Type: Article

References (29)

1. Melnick, A. & Licht, J.D. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215 (1999)
2. Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. & de Thé, H. PML nuclear bodies and apoptosis. Oncogene 23, 2819-2824 (2004).
3. Jensen, K., Shiels, C. & Freemont, P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233 (2001).
4. Wang, Z.G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551 (1998).
5. Gurrieri, C. et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 96, 269-279 (2004).
6. Zhong, S., Muller, S., Freemont, P.S., Dejean, A. & Pandolfi, P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2753 (2000).
7. Salomoni, P. & Pandolfi, P.P. The role of PML in tumor suppression. Cell 108, 165-170 (2002).
8. Zhong, S., Salomoni, P. & Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90 (2000).
9. Scolnick, D.M. & Halazonetis, T.D. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 406, 430-435 (2000).
10. Chaturvedi, P, et al. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res. 62, 1797-1801 (2002).
11. Spector, D.L. Nuclear domains. J. Cell Sci. 114, 2891-2893 (2001).
12. Muller, S., Matunis, M.J. & Dejean, A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70 (1998).
13. Jares-Erijman, E.A. & Jovin, T.M. FRET imaging. Nat. Biotechnol. 21, 1387-1395 (2003).
14. Rieder, C.L. & Cole, R. Microtubule disassembly delays the G2-M transition in vertebrates. Curr. Biol. 10, 1067-1070 (2000).
15. Bothos, J., Summers, M.K., Venere, M., Scolnick, D.M. & Halazonetis, T.D. The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains. Oncogene 22, 7101-7107 (2003).
16. Chang, K.S., Fan, Y.H., Andreeff, M., Liu, J. & Mu, Z.M. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85, 3646-3653 (1995).
17. Kang, D., Chen, J., Wong, J. & Fang, G. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J. Cell Biol. 156, 249-259 (2002).
18. Aravind, L., Iyer, L.M. & Koonin, E.V. Scores of RINGS but no PHDs in ubiquitin signaling. Cell Cycle 2, 123-126 (2003).
19. Boisvert, F-M., Hendzel, M. & Bazlett-Jones, D.P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292 (2000).
20. Corn, P.G. et al. Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. Carcinogenesis, 24, 47-51 (2003).
21. Toyota, M. et al. Epigenetic inactivation of CHFR in human tumors. Proc. Natl. Acad. Sci. USA 100, 7818-7823 (2003).
22. Mariatos, G. et al. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer. Cancer Res. 63, 7185-7189 (2003).
23. Satoh, A. et al. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res. 63, 8606-8613 (2003).
24. Sakaguchi, D.S., Coffman, C.R., Gallenson, N. & Harris, W.A. A glial cell line promotes the outgrowth of neuritis from embryonic Xenopus retina. Acta Biol. Hung. 39, 201-209 (1988).
25. Manders, E.M., Stap, J., Brakenhoff, G., van Driel, R. & Aten, J.A. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J. Cell Sci. 103, 857-862 (1992).
26. Bastiaens, P.I., Majoul, I.V., Verveer, P.J., Soling, H.D. & Jovin, T.M. Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J. 15, 4246-4253 (1996).
27. Ellenberg, J. et al. Nuclear membrane dynamics and reassembly in living cells: targeting of an inner nuclear membrane protein in interphase and mitosis. J. Cell Biol. 138, 1193-1206 (1997).
28. Yu, D.S. et al. Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2. Mol. Cell 12, 1029-1041 (2003).
29. Earnshaw, W.C. Mitotic chromosome structure. Bioessays 9, 147-150 (1988).